Resource
Durable Clinical Responses With Rondecabtagene Autoleucel (Dual-Targeting CD19/CD20 CAR-T Cell) are Associated With Higher Proportion of Cytotoxic T Cells With Memory Potential in Infusion Products
Publication Date: June 11, 2026
Source: The European Hematology Association (EHA)
Author(s): Akil Merchant, Tahir Latif, Umar Farooq, Locke Bryan, Stefan O. Ciurea, Nebu Koshy, Ben Harris, Viola Lam, Shobha Potluri, Sarah M. Larson
Resource Type: Poster